S&P 500   3,823.40 (+0.10%)
DOW   31,322.10 (+0.17%)
QQQ   307.25 (-0.62%)
AAPL   121.48 (-0.48%)
MSFT   227.86 (+0.13%)
FB   256.91 (+0.59%)
GOOGL   2,020.86 (+0.47%)
TSLA   637.50 (-2.40%)
AMZN   3,018.20 (+0.44%)
NVDA   503.13 (-1.77%)
BABA   232.43 (-1.63%)
CGC   31.66 (-4.75%)
GE   13.62 (+1.34%)
MU   85.73 (-3.79%)
NIO   39.63 (-4.58%)
AMD   79.20 (-2.05%)
T   29.16 (+1.53%)
F   12.11 (-0.49%)
ACB   10.03 (-4.11%)
DIS   188.98 (-1.71%)
BA   232.24 (+1.61%)
NFLX   519.00 (-0.33%)
PFE   34.72 (+0.96%)
S&P 500   3,823.40 (+0.10%)
DOW   31,322.10 (+0.17%)
QQQ   307.25 (-0.62%)
AAPL   121.48 (-0.48%)
MSFT   227.86 (+0.13%)
FB   256.91 (+0.59%)
GOOGL   2,020.86 (+0.47%)
TSLA   637.50 (-2.40%)
AMZN   3,018.20 (+0.44%)
NVDA   503.13 (-1.77%)
BABA   232.43 (-1.63%)
CGC   31.66 (-4.75%)
GE   13.62 (+1.34%)
MU   85.73 (-3.79%)
NIO   39.63 (-4.58%)
AMD   79.20 (-2.05%)
T   29.16 (+1.53%)
F   12.11 (-0.49%)
ACB   10.03 (-4.11%)
DIS   188.98 (-1.71%)
BA   232.24 (+1.61%)
NFLX   519.00 (-0.33%)
PFE   34.72 (+0.96%)
S&P 500   3,823.40 (+0.10%)
DOW   31,322.10 (+0.17%)
QQQ   307.25 (-0.62%)
AAPL   121.48 (-0.48%)
MSFT   227.86 (+0.13%)
FB   256.91 (+0.59%)
GOOGL   2,020.86 (+0.47%)
TSLA   637.50 (-2.40%)
AMZN   3,018.20 (+0.44%)
NVDA   503.13 (-1.77%)
BABA   232.43 (-1.63%)
CGC   31.66 (-4.75%)
GE   13.62 (+1.34%)
MU   85.73 (-3.79%)
NIO   39.63 (-4.58%)
AMD   79.20 (-2.05%)
T   29.16 (+1.53%)
F   12.11 (-0.49%)
ACB   10.03 (-4.11%)
DIS   188.98 (-1.71%)
BA   232.24 (+1.61%)
NFLX   519.00 (-0.33%)
PFE   34.72 (+0.96%)
S&P 500   3,823.40 (+0.10%)
DOW   31,322.10 (+0.17%)
QQQ   307.25 (-0.62%)
AAPL   121.48 (-0.48%)
MSFT   227.86 (+0.13%)
FB   256.91 (+0.59%)
GOOGL   2,020.86 (+0.47%)
TSLA   637.50 (-2.40%)
AMZN   3,018.20 (+0.44%)
NVDA   503.13 (-1.77%)
BABA   232.43 (-1.63%)
CGC   31.66 (-4.75%)
GE   13.62 (+1.34%)
MU   85.73 (-3.79%)
NIO   39.63 (-4.58%)
AMD   79.20 (-2.05%)
T   29.16 (+1.53%)
F   12.11 (-0.49%)
ACB   10.03 (-4.11%)
DIS   188.98 (-1.71%)
BA   232.24 (+1.61%)
NFLX   519.00 (-0.33%)
PFE   34.72 (+0.96%)
Log in
ASX:RNO

Rhinomed Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.07
MA: A$0.07
A$0.07
52-Week Range N/A
Volume452,773 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Rhinomed (ASX:RNO) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying RNO stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Rhinomed, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Rhinomed (ASX:RNO) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Profitability

This table compares Rhinomed and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RhinomedN/AN/AN/A
(CHV)N/AN/AN/A

Earnings & Valuation

This table compares Rhinomed and (CHV)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rhinomed$4.58 million0.00$-8,883,314.72A($0.04)N/A
(CHV)N/AN/AN/AN/AN/A

(CHV) has lower revenue, but higher earnings than Rhinomed.

Analyst Ratings

This is a breakdown of recent ratings for Rhinomed and (CHV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Rhinomed0000N/A
(CHV)0000N/A

Summary

Rhinomed beats (CHV) on 1 of the 1 factors compared between the two stocks.

Rhinomed (ASX:RNO) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of recent ratings for Rhinomed and (DDXS), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Rhinomed0000N/A
(DDXS)0000N/A

Profitability

This table compares Rhinomed and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RhinomedN/AN/AN/A
(DDXS)N/AN/AN/A

Earnings & Valuation

This table compares Rhinomed and (DDXS)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rhinomed$4.58 million0.00$-8,883,314.72A($0.04)N/A
(DDXS)N/AN/AN/AN/AN/A

(DDXS) has lower revenue, but higher earnings than Rhinomed.

Summary

Rhinomed beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Rhinomed (ASX:RNO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

Profitability

This table compares (PREV) and Rhinomed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
RhinomedN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for (PREV) and Rhinomed, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Rhinomed0000N/A

Earnings and Valuation

This table compares (PREV) and Rhinomed's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Rhinomed$4.58 million0.00$-8,883,314.72A($0.04)N/A

(PREV) has higher earnings, but lower revenue than Rhinomed.

Summary

Rhinomed beats (PREV) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and Rhinomed (ASX:RNO) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Valuation and Earnings

This table compares (TNGN) and Rhinomed's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
Rhinomed$4.58 million0.00$-8,883,314.72A($0.04)N/A

(TNGN) has higher earnings, but lower revenue than Rhinomed.

Profitability

This table compares (TNGN) and Rhinomed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
RhinomedN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for (TNGN) and Rhinomed, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Rhinomed0000N/A

Summary

Rhinomed beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Rhinomed (ASX:RNO) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Earnings and Valuation

This table compares Rhinomed and 138267 (COM.TO)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rhinomed$4.58 million0.00C$-8,883,314.72A($0.04)N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

138267 (COM.TO) has lower revenue, but higher earnings than Rhinomed.

Profitability

This table compares Rhinomed and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RhinomedN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Rhinomed and 138267 (COM.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Rhinomed0000N/A
138267 (COM.TO)0000N/A

Summary

Rhinomed beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Rhinomed (ASX:RNO) and 17031 (CNSX:MYM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Rhinomed and 17031, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Rhinomed0000N/A
170310000N/A

Profitability

This table compares Rhinomed and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
RhinomedN/AN/AN/A
17031N/AN/AN/A

Earnings and Valuation

This table compares Rhinomed and 17031's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rhinomed$4.58 million0.00C$-8,883,314.72A($0.04)N/A
17031N/AN/AN/AN/AN/A

17031 has lower revenue, but higher earnings than Rhinomed.

Summary

Rhinomed beats 17031 on 1 of the 1 factors compared between the two stocks.


Rhinomed Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00News Coverage
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3$300.00flat£0.00N/A0.00
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Down
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADTX
ADiTx Therapeutics
1.0$2.79flat$0.00N/A0.00Decrease in Short Interest
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.25flat$0.00N/A0.00Gap Up
Almirall logo
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00Increase in Short Interest
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.03flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$31.36flat$0.00N/A0.00
AXIM
AXIM Biotechnologies
0.4$0.67flat$0.00N/A0.00News Coverage
Gap Down
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
BGT
Bio-Gene Technology
0.8N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.15 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$100,744.000.00High Trading Volume
Gap Up
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.37flat$0.00N/A0.00Gap Down
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.10flat$0.00N/A0.00Increase in Short Interest
Gap Down
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$18.35flat$0.00N/A0.00Gap Up
CUV
Clinuvel Pharmaceuticals
1.0N/AN/A$0.00$38.34 million0.00High Trading Volume
News Coverage
Gap Up
CELZ
Creative Medical Technology
0.5$0.03flat$0.00N/A0.00Decrease in Short Interest
CSL logo
CSL
CSL
0.8N/AN/A$0.00$9.98 billion0.00High Trading Volume
News Coverage
Gap Up
CLXPF
Cybin
1.0$1.23flat$0.00N/A0.00Decrease in Short Interest
Gap Down
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.60 million0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00High Trading Volume
Gap Down
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.39flat$0.00N/A0.00Gap Down
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.